Literature DB >> 19811059

Management of benign ureteral strictures in the endoscopic era.

Anthony T Corcoran1, Marc C Smaldone, Daniel D Ricchiuti, Timothy D Averch.   

Abstract

BACKGROUND AND
PURPOSE: During the past decade, endoscopic management has emerged as the first-line treatment of benign ureteral strictures. We reviewed our experience with the management of benign ureteral strictures to determine the success rate of endoscopic surgery in a contemporary series and assessed the viability of surgical reimplantation in the modern era. PATIENTS AND METHODS: We identified 75 patients with a diagnosis of ureteral stricture between 2000 and 2005 via electronic medical records search and excluded those with completely obliterated, external compressive, malignant, or ureteroenteric strictures, ureteropelvic junction obstruction, and those with follow-up less than 2 months.
RESULTS: Thirty-four patients who were treated endoscopically (balloon dilation and/or holmium laser endoureterotomy) were identified. Mean stricture length in each patient was 1.6 +/- 1 cm (range 0.5-4 cm), and the mean number of procedures per patient was 1.7 +/- 0.8. Endoscopic success was achieved in 29 (85%), while 5 (15%) patients experienced endoscopic management failure and ultimately needed ureteral reimplantation. When comparing the endoscopically treated and reimplant groups, there was no significant difference in mean stricture length (1.38 +/- 1.13 vs 2 +/- 1.1 cm, P = 0.14), yet mean number of procedures performed (1.41 +/- 0.85 vs 3.6 +/- 1.5; P = 0.002) reached statistical significance. There were no clinical or radiographic signs of obstruction in 100% of patients who received endoscopic therapy only and 100% of patients who needed open surgical management at a mean follow-up of 25.2 +/- 19.3 and 7.7 +/- 3.2 months, respectively.
CONCLUSIONS: Endoscopic surgery is clearly a successful primary treatment modality in the management of benign ureteral strictures with minimal morbidity. In the modern era of endoscopic surgery, however, ureteral reimplantation remains a viable option in treating the small subset of patients with benign ureteral strictures for whom endoscopic management fails.

Entities:  

Mesh:

Year:  2009        PMID: 19811059     DOI: 10.1089/end.2008.0453

Source DB:  PubMed          Journal:  J Endourol        ISSN: 0892-7790            Impact factor:   2.942


  7 in total

1.  A guidewire introducer as a ureteral foreign body: A case report.

Authors:  Tarik Emre Sener; Jonathan Cloutier; Marie Audouin; Luca Villa; Olivier Traxer
Journal:  Can Urol Assoc J       Date:  2015 May-Jun       Impact factor: 1.862

Review 2.  Laser endoureterotomy and endopyelotomy: an update.

Authors:  Esteban Emiliani; Alberto Breda
Journal:  World J Urol       Date:  2014-09-23       Impact factor: 4.226

3.  Evaluation of risk factors and treatment options in patients with ureteral stricture disease at a single institution.

Authors:  Henry Tran; Olga Arsovska; Ryan F Paterson; Ben H Chew
Journal:  Can Urol Assoc J       Date:  2015-12-14       Impact factor: 1.862

Review 4.  Endoscopic Management of Ureteral Strictures: an Update.

Authors:  Jacob W Lucas; Eric Ghiraldi; Jeffrey Ellis; Justin I Friedlander
Journal:  Curr Urol Rep       Date:  2018-03-02       Impact factor: 3.092

5.  Heparin coating in biodegradable ureteral stents does not decrease bacterial colonization-assessment in ureteral stricture endourological treatment in animal model.

Authors:  Federico Soria; Julia E de La Cruz; Tomás Fernandez; Alberto Budia; Álvaro Serrano; Francisco M Sanchez-Margallo
Journal:  Transl Androl Urol       Date:  2021-04

6.  Endoscopic Procedures in the Treatment of Ureteroenteric Anastomotic Strictures: A Systematic Review and Meta-Analysis.

Authors:  Xun Lu; Yiduo Wang; Qi Chen; Di Xia; Hanyu Zhang; Ming Chen
Journal:  Front Surg       Date:  2021-04-14

7.  Updates on the use of ureteral stents: focus on the Resonance(®) stent.

Authors:  Manoj V Rao; Anthony J Polcari; Thomas Mt Turk
Journal:  Med Devices (Auckl)       Date:  2010-12-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.